2026-09-24 10:01:49 UTC / 路透社
作者：艾哈迈德·阿布勒埃宁
2026年9月24日 10:01 AM UTC 1小时前更新
医疗保险和医疗补助服务中心主任穆罕默德·奥兹博士、美国卫生与公众服务部部长小罗伯特·F·肯尼迪以及美国总统唐纳德·特朗普在华盛顿白宫校区礼堂举行的医疗成本与可负担性讲话活动中站立，海蒂·奥弗顿正在发言。 购买授权，打开新标签页查看更多
- 内容摘要
- 奥弗顿是白宫高级助手，特朗普的盟友，拥有反堕胎立场
- 她将接手FDA对堕胎药物米非司酮的审查工作
- 参议院劳工与人力资源委员会主席卡西迪预计将就疫苗问题对她进行质询
- 委员会还将对卫生局局长提名候选人妮可·萨皮尔进行投票表决
华盛顿9月24日路透电 — 美国参议院卫生委员会将于周四举行听证会，就唐纳德·特朗普总统提名的海蒂·奥弗顿出任陷入困境的FDA负责人一职进行确认，同时还将推进特朗普提名的卫生局局长人选的审议程序。
特朗普于今年8月提名白宫政策助手奥弗顿，这位奉行“美国优先”理念的盟友将接手因人员流失、士气低落以及在疫苗、堕胎药物和药品审批问题上的争执而陷入动荡的机构。
通过《每日案卷》时事通讯将最新法律新闻直接发送至您的收件箱，开启您的清晨资讯之旅。 在此注册。
广告 · 滚动继续阅读
如果获得确认，奥弗顿将接管美国食品药品监督管理局，该局在过去一年中已流失超过3000名员工，包括各部门负责人，目前正面临着重建行业和公共卫生团体信任的压力。
这家负责监管和批准所有药品、治疗方案和疫苗的机构，因被指过于政治化而引发担忧。
奥弗顿是一名预防医学医师，同时担任白宫国内政策委员会副主任，此前曾在保守派智库“美国优先政策研究所”任职。她的提名恰逢特朗普政府官员在自闭症、疫苗和堕胎药物领域推出新举措之际。
广告 · 滚动继续阅读
参议院劳工与人力资源委员会共和党主席、路易斯安那州参议员比尔·卡西迪本身也是一名医师，他对本届政府的免疫接种政策持越来越多的批评态度，预计将就疫苗问题对奥弗顿进行质询。
奥弗顿曾在上个月的一场白宫活动中发言，当时特朗普签署了一项行政命令，旨在缩减儿童疫苗接种计划，将麻疹、腮腺炎和风疹联合疫苗拆分为三针单独接种，这一举措遭到了医师团体和疫苗制造商的强烈反对。
奥弗顿还可能被问及，如果被要求采取她认为不科学或非法的行动，她是否会违抗卫生部长小罗伯特·F·肯尼迪——一名长期反疫苗活动人士——或特朗普。这一问题已成为近期特朗普政府卫生官员提名确认听证会的常客。
预计奥弗顿的反堕胎立场将引来民主党人的审视和堕胎权利倡导者的反对。奥弗顿曾称最高法院2022年推翻罗伊诉韦德案的裁决是“生命的巨大胜利”，反堕胎团体也对她的提名表示欢迎。
blob:https://www.reuters.com/03f11973-11ac-4444-9864-abe9d9acbd6b
如果获得确认，奥弗顿将接手FDA对堕胎药物米非司酮的审查工作，堕胎权利组织称这项审查具有政治动机，可能导致对该药物实施更严格的限制。该局面临着在10月7日前向联邦法院通报审查进展的最后期限。
委员会还将对妮可·萨皮尔出任卫生局局长一职进行投票表决。萨皮尔是一名放射科医师，也曾是福克斯新闻撰稿人，是特朗普提名的第三位该职位候选人。
萨皮尔上周在听证会上就儿童疫苗问题接受了质询，她表示支持免疫接种，尽管她所在的政府正在寻求对疫苗指南进行全面改革。当被卡西迪追问疫苗是否不会导致自闭症（这一已被证伪的关联正是肯尼迪所宣扬的，与科学证据相悖）时，她最终表态称疫苗不会引发自闭症。
自特朗普2025年1月就职以来，美国一直没有正式的卫生局局长，而FDA自马蒂·马卡里博士今年5月因与白宫官员发生冲突辞职以来，也一直没有常设负责人。
广告 · 滚动继续阅读
艾哈迈德·阿布勒埃宁 报道
比尔·伯克罗特 编辑
我们的标准：汤森路透信任原则。
Trump’s FDA pick to face vaccine, abortion pill questions at US Senate hearing
2026-09-24 10:01:49 UTC / Reuters
By Ahmed Aboulenein
September 24, 2026 10:01 AM UTC Updated 1 hour ago
Centre for Medicare & Medicaid Services Administrator Dr Mehmet Oz, U.S. Health and Human Services Secretary Robert F. Kennedy Jr., and U.S. President Donald Trump stand as Heidi Overton speaks during an event to deliver remarks about health care costs and affordability from an auditorium on the White House campus in Washington,… Purchase Licensing Rights, opens new tabRead more
- Summary
- Overton, a senior White House aide, is a Trump ally with anti-abortion ties
- She would inherit an FDA review of abortion pill mifepristone
- HELP Committee chair Cassidy expected to press her on vaccines
- Panel also votes on surgeon general nominee Nicole Saphier
WASHINGTON, Sept 24 (Reuters) – The US Senate health committee will hold a confirmation hearing on Thursday for Heidi Overton, President Donald Trump’s pick to lead the embattled FDA, as it also weighs advancing his surgeon general nominee.
Trump nominated Overton, a White House policy aide, in August, turning to an “America First” ally to steady an agency shaken by staff losses, low morale and fights over vaccines, the abortion pill and drug approvals.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
If confirmed, Overton will take over a Food and Drug Administration that has lost more than 3,000 staff over the past year, including division heads, and is under pressure to rebuild confidence among industry and public-health groups.
The agency, responsible for regulating and approving all drugs, treatments and vaccines, has faced concerns it has become too political.
Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, previously worked at the America First Policy Institute, a conservative think tank. Her nomination coincides with new initiatives from Trump health officials on autism, vaccines and the abortion pill.
Advertisement · Scroll to continue
Senator Bill Cassidy of Louisiana, the panel’s Republican chairman and a physician increasingly critical of the administration’s approach to immunization, is likely to press Overton on vaccines.
She spoke at a White House event last month where Trump signed an executive order seeking to cut back the childhood vaccination schedule and split the measles, mumps and rubella vaccine into three shots, a move physicians’ groups and vaccine makers strongly oppose.
Overton is also likely to be pressed on whether she would defy Health Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist, or Trump, if ordered to take actions she deems unscientific or illegal. That question has become a fixture of recent confirmation hearings for Trump health nominees.
Overton’s anti-abortion views are expected to draw Democratic scrutiny and opposition from abortion-rights advocates. Overton called the Supreme Court’s 2022 decision overturning Roe v. Wade “a huge victory for life,” and anti-abortion groups have welcomed her nomination.
blob:https://www.reuters.com/03f11973-11ac-4444-9864-abe9d9acbd6b
If confirmed, Overton would inherit an FDA review of the abortion pill mifepristone that abortion-rights groups say is politically motivated and that could lead to tighter restrictions on the drug. The agency faces an October 7 deadline to update a federal court on its progress.
The committee is also scheduled to vote on Nicole Saphier, a radiologist and former Fox News contributor, for surgeon general.
Saphier, Trump’s third nominee, was grilled last week on childhood vaccines, voicing support for immunization as she seeks a role in an administration pursuing sweeping changes to vaccine guidance. Pressed by Cassidy to say vaccines do not cause autism, a debunked link that Kennedy has promoted contrary to scientific evidence, she eventually agreed they do not.
The United States has had no surgeon general since Trump took office in January 2025, and the FDA has lacked a permanent leader since Dr. Marty Makary resigned in May after clashes with White House officials.
Advertisement · Scroll to continue
Reporting by Ahmed Aboulenein Editing by Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles.
发表回复